2020 Lautenberg Center Progress Report

42
6. ENCODE Project Consortium, Moore JE, Purcaro MJ, Pratt HE, Epstein CB, Shoresh
N, Adrian J, Kawli T, Davis CA, Dobin A, Kaul R, Halow J, Van Nostrand EL, Freese P,
Gorkin DU, Shen Y, He Y, Mackiewicz M, Pauli-Behn F, Williams BA, Mortazavi A, Keller
CA, Zhang XO, Elhajjajy SI, Huey J, Dickel DE, Snetkova V, Wei X, Wang X, Rivera-Mulia
JC, Rozowsky J, Zhang J, Chhetri SB, Zhang J, Victorsen A, White KP, Visel A, Yeo GW,
Burge CB, Lécuyer E, Gilbert DM, Dekker J, Rinn J, Mendenhall EM, Ecker JR, Kellis M,
Klein RJ, Noble WS, Kundaje A, Guigó R, Farnham PJ, Cherry JM, Myers RM, Ren B,
Graveley BR, Gerstein MB, Pennacchio LA, Snyder MP, Bernstein BE, Wold B, Hardison
RC, Gingeras TR, Stamatoyannopoulos JA, Weng Z: Expanded encyclopaedias of DNA
elements in the human and mouse genomes. Nature 2020, 583(7818):699-710.
7. ENCODE Project Consortium, Snyder MP, Gingeras TR, Moore JE, Weng Z, Gerstein
MB, Ren B, Hardison RC, Stamatoyannopoulos JA, Graveley BR, Feingold EA, Pazin MJ,
Pagan M, Gilchrist DA, Hitz BC, Cherry JM, Bernstein BE, Mendenhall EM, Zerbino DR,
Frankish A, Flicek P, Myers RM: Perspectives on ENCODE. Nature 2020, 583(7818):693-
698.
8. Flavahan WA*, Drier Y* § , Johnstone S, Hemming, ML, Tarjan D, Hegazi E, Shareef SJ,
Javed NM, Raut CP, Eschle BK, Gokhale PC, Hornick JL, Sicinska ET, Demetri GD § ,
Bernstein BE § : Altered chromosomal topology drives oncogenic programs in SDHdeficient
GIST. Nature 2019, 575(7781), 229–233. * Equal Authorship, § Corresponding
author.
9. Cejas P*, Drier Y* § , Dreijerink KMA, Brosens LAA, Deshpande V, Epstein CB, Conemans
EB, Morsink FHM, Graham MK, Valk GD, Vriens MR, Fernandez-del Castillo C, Ferrone
C, Adar T, Bowden M, Whitton HJ, Da Silva A, Font-Tello A, Long HW, Gaskell E, Shoresh
N, Heaphy CM, Sicinska E, Kulke MH, Chung DC, Bernstein BE § , Shivdasani RA § :
Enhancer signatures stratify and predict outcomes of non-functional pancreatic
neuroendocrine tumors. Nature Medicine 2019, 25(8):1260-1265. * Equal Authorship, §
Corresponding author.
10. Raoof S*, Mulford IJ*, Frisco-Cabanos H, Nangia V, Timonina D, Labrot E, Hafeez N,
Bilton SJ, Drier Y, Ji F, Greenberg M, Williams A, Kattermann K, Damon L, Sovath S,
Rakiec DP, Korn JM, Ruddy DA, Benes CH, Hammerman PS, Piotrowska Z, Sequist LV,
Niederst MJ, Barretina J, Engelman JA, Hata AN: Targeting FGFR overcomes EMTmediated
resistance in EGFR mutant non-small cell lung cancer. Oncogene 2019,
38(37):6399-6413.